Status:
COMPLETED
Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC
Lead Sponsor:
Samsung Medical Center
Conditions:
Thyroid Neoplasm
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Objective: To investigate the incidence of lateral neck node occult metastasis and to show the usefulness of sentinel lymph node biopsy (SLNB) in the detection of lateral neck node metastasis in thyro...
Detailed Description
On the day of the operation, patients underwent preoperative lymphoscintigraphy after the intratumoral injection of a Tc-99m phytate 1 mCi in 0.1-0.2 mL 0.9% NaCl under ultrasonographic guidance. Tota...
Eligibility Criteria
Inclusion
- Cases with tumors larger than 1 cm in size or with suspicious central neck node metastasis in Papillary thyroid cancer
Exclusion
- The patient with definite metastatic lymph node in lateral neck compartment
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT01137097
Start Date
June 1 2009
End Date
January 1 2011
Last Update
April 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710